Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1 1

Status

Completed 8Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 192Neoplasms 148Prostatic Neoplasms 101Lung Neoplasms 90Carcinoma, Non-Small-Cell Lung 62Colorectal Neoplasms 59Head and Neck Neoplasms 52Pancreatic Neoplasms 46Carcinoma, Hepatocellular 44Rectal Neoplasms 42Brain Neoplasms 41Multiple Myeloma 40Colonic Neoplasms 37Esophageal Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 30Leukemia, Myeloid, Acute 30Ovarian Neoplasms 29Lymphoma, Non-Hodgkin 29Leukemia 29Lymphoma 28Motor Activity 26Hodgkin Disease 24Uterine Cervical Neoplasms 23Carcinoma, Renal Cell 23Pain 22Lymphoma, Follicular 22Depression 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioma 21

Interventions

Sorafenib 1Immunoglobulins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Terminated × Neurologic Manifestations × Clear all
NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

FDA Office of Orphan Products Development

Phase NA Terminated
100 enrolled

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases

NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
2 enrolled 6 charts
BreastCNS

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡